 |
PDBsum entry 4cmh
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/immune system
|
PDB id
|
|
|
|
4cmh
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
240 a.a.
|
 |
|
|
|
|
|
|
|
216 a.a.
|
 |
|
|
|
|
|
|
|
213 a.a.
|
 |
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/immune system
|
 |
|
Title:
|
 |
Crystal structure of cd38 with a novel cd38-targeting antibody sar650984
|
|
Structure:
|
 |
Adp-ribosyl cyclase 1. Chain: a. Fragment: extracellular domain, residues 45-300. Synonym: cyclic adp-ribose hydrolase 1, cadpr hydrolase 1, t10, cd38, acyl-ribose cyclase 1. Engineered: yes. Mutation: yes. Heavy chain of sar650984-fab fragment. Chain: b.
|
|
Source:
|
 |
Homo sapiens. Organism_taxid: 9606. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: hek-293t. Mus musculus. House mouse. Organism_taxid: 10090. Organism_taxid: 10090
|
|
Resolution:
|
 |
|
1.53Å
|
R-factor:
|
0.189
|
R-free:
|
0.208
|
|
|
Authors:
|
 |
J.Deckert,M.C.Wetzel,P.U.Park,L.M.Bartle,A.Skaletskaya,V.Goldmacher, F.Vallee,Q.Zhouliu,P.Ferrari,S.Pouzieux,C.Lahoute,C.Dumontet, A.Plesa,M.Chiron,P.Lejeune,T.Chittenden,V.Blanc
|
|
Key ref:
|
 |
J.Deckert
et al.
(2014).
SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies.
Clin Cancer Res,
20,
4574-4583.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
15-Jan-14
|
Release date:
|
16-Jul-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P28907
(CD38_HUMAN) -
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
300 a.a.
240 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain A:
E.C.2.4.99.20
- 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
nicotinate + NADP+ = nicotinate-adenine dinucleotide phosphate + nicotinamide
|
 |
 |
 |
 |
 |
nicotinate
|
+
|
NADP(+)
|
=
|
nicotinate-adenine dinucleotide phosphate
|
+
|
nicotinamide
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chain A:
E.C.3.2.2.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chain A:
E.C.3.2.2.6
- ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
NAD+ + H2O = ADP-D-ribose + nicotinamide + H+
|
 |
 |
 |
 |
 |
NAD(+)
|
+
|
H2O
|
=
|
ADP-D-ribose
|
+
|
nicotinamide
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Clin Cancer Res
20:4574-4583
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies.
|
|
J.Deckert,
M.C.Wetzel,
L.M.Bartle,
A.Skaletskaya,
V.S.Goldmacher,
F.Vallée,
Q.Zhou-Liu,
P.Ferrari,
S.Pouzieux,
C.Lahoute,
C.Dumontet,
A.Plesa,
M.Chiron,
P.Lejeune,
T.Chittenden,
P.U.Park,
V.Blanc.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |